Literature DB >> 2941259

Comparative in vitro studies with 4-quinolone antimicrobials.

D Felmingham, M D O'Hare, M J Robbins, R A Wall, A H Williams, A W Cremer, G L Ridgway, R N Grüneberg.   

Abstract

The minimal inhibitory concentrations (MICs) of nalidixic acid, pipemidic acid, cinoxacin, oxolinic acid, flumequine, pefloxacin, acrosoxacin, amifloxacin, norfloxacin, enoxacin, ofloxacin and ciprofloxacin were determined for a range of clinical isolates. MICs were determined using an agar dilution technique in Mueller-Hinton agar supplemented with 10% lysed horse blood. The inoculum used was approximately 10(4) colony forming units, contained in 10 microliters Mueller-Hinton broth, which was applied to the agar plates using a multipoint inoculator. Following inoculation, plates were incubated in conditions appropriate for the organisms under investigation. The MIC of each antimicrobial for each isolate examined was determined as the lowest concentration of the antimicrobial which completely inhibited growth of the inoculum. The minimum concentrations required to inhibit the growth of 50% (MIC50) and 90% (MIC90) of the organisms examined were also determined. All of the more recently synthesised 4-quinolones showed considerably greater activity than the parent compounds, nalidixic acid, pipemidic acid and cinoxacin, against the range of organisms used in this study. Ciprofloxacin and ofloxacin were the two most active of the 4-quinolones examined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2941259

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  23 in total

1.  Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline.

Authors:  P M Bath; K W Pettingale; J Wade
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Penetration of pefloxacin into bronchial secretions.

Authors:  G Bonmarchand; J J Grès; G Lerebours; P Massari; J J Mayoux; A Montay; J Leroy
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Authors:  D Schlenkhoff; A Dalhoff; J Knopf; W Opferkuch
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 4.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 5.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

6.  Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland.

Authors:  O V Renkonen; A Sivonen; R Visakorpi
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

7.  Synthesis and antibacterial properties of new 8-nitrofluoroquinolone derivatives.

Authors:  Yusuf M Al-Hiari; Inas Saleh Al-Mazari; Ashok K Shakya; Rula M Darwish; Rana Abu-Dahab
Journal:  Molecules       Date:  2007-06-30       Impact factor: 4.411

Review 8.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Single and multiple dose pharmacokinetics of ciprofloxacin in gynecological tissues.

Authors:  G J Gerstner; A Dalhoff; H Weuta
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 10.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.